Ginkgo Bioworks DNA UNITED STATES — Concentration risk
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's united states — concentration risk.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's UNITED STATES — concentration risk?
- Ginkgo Bioworks (DNA) reported UNITED STATES — concentration risk of 66% in Q1 2026.
- How has Ginkgo Bioworks's UNITED STATES — concentration risk changed year-over-year?
- Ginkgo Bioworks's UNITED STATES — concentration risk decreased by 18.5% year-over-year, from 81% to 66%.
- What does UNITED STATES — concentration risk mean?
- This metric measures the proportion of total segment revenue derived from a limited number of key customers or a single major contract within the United States market. A high concentration indicates significant dependency on specific client relationships, which poses a risk to revenue stability if those partnerships are terminated or renegotiated. Monitoring this ratio helps investors assess the diversification of the revenue base and the potential impact of client-specific volatility on the segment's financial performance.